Tonicity response element binding protein associated with neuronal cell death in the experimental diabetic retinopathy

International Journal of Ophthalmology

Volumn 7, Issue 6, 2014, Pages 935-940

  Kim, Seong Jae ^a,b   Kim, Hwajin ^a,b   Park, Jeongsook ^a,b   Chung, Inyoung ^a,b   Kwon, Hyug Moo ^c   Choi, Wan Sung ^a,b   Yoo, Ji Myong ^a,b  

^a Gyeongsang National University School of Medicine   (South Korea)

^b Gyeongsang National University   (South Korea)

^c Ulsan National Institute of Science and Technology   (South Korea)

Author keywords

Aldose reductase; Diabetes; Retinopathy; Tonicity response element binding protein

Indexed keywords

EID: 84925452356     PISSN: 22223959     EISSN: 22274898     Source Type: Journal    
DOI: 10.3980/j.issn.2222-3959.2014.06.04     Document Type: Article

References (21)

1. Hazin R, Colyer M, Lum F, Barazi MK, Revisiting Diabetes 2000: challenges in establishing nationwide diabetic retinopathy prevention programs. Am J Ophthalmol 2011;152(5):723-729.
2. Antonetti DA, Barber AJ, Bronson SK, Freeman WM, Gardner TW, Jefferson LS, Kester M, Kimball SR, Krady JK, LaNoue KF, Norbury CC, Quinn PG, Sandirasegarane L, Simpson IA; JDRF Diabetic Retinopathy Center Group. Diabetic retinopathy: seeing beyond glucose-induced microvascular disease. Diabetes 2006;55(9):2401-2411.
3. Lieth E, Gardner TW, Barber AJ, Antonetti DA; Penn State Retina Research Group. Retinal neurodegeneration: early pathology in diabetes. Clin Experiment Ophthalmol 2000;28(1):3-8.
4. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005;54(6): 1615-1625.
5. Hattori T, Matsubara A, Taniguchi K, Ogura Y. Aldose reductase inhibitor fidarestat attenuates leukocyte-endothelial interactions in experimental diabetic rat retina in vivo Curr Eye Res 2010;35(2):146-154.
6. Rosas-Rodríguez JA, Valenzuela-Soto EM. Enzymes involved in osmolyte synthesis: how does oxidative stress affect osmoregulation in renal cells? Life Sci 2010;23(17-18):515-520.
7. Irarrazabal CE, Gallazzini M, Schnetz MP, Kunin M, Simons BL, Williams CK, Burg MB, Ferraris JD. Phospholipase C-gamma1 is involved in signaling the activation by high NaCl of the osmoprotective transcription factor TonEBP/OREBP. Proc Natl Acad Sci USA 2010;107(2):906-911.
8. Cheung CY, Ko BC. NFAT5 in cellular adaptation to hypertonic stress-regulations and functional significance. J Mol signal 2013;8(1):5.
9. Yang B, Hodgkinson AD, Oates PJ, Kwon HM, Millward BA, Demaine AG. Elevated activity of transcription factor nuclear factor of activated T-cells 5 (NFAT5) and diabetic nephropathy. Diabetes 2006;55 (5): 1450-1455.
10. Kim YH, Kim YS, Kang SS, Noh HS, Kim HJ, Cho GJ, Choi WS. Expression of 14-3-3 zeta and interaction with protein kinase C in the rat retina in early diabetes. Diabetologia 2005;48(7): 1411-1415.
11. Kim YH, Kim YS, Noh HS, Kang SS, Cheon EW, Park SK, Lee BJ, Choi WS, Cho GJ. Changes in rhodopsin kinase and transducin in the rat retina in early-stage diabetes. Exp Eye Res 2005;80(6):753-760.
12. Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest 1998;102 (4): 783-791.
13. Oshitari T, Hata N, Yamamoto S. Endoplasmic reticulum stress and diabetic retinopathy. Vasc Health. Risk Manag 2008;4(1):115-122.
14. Hotta N, Kawamori R, Fukuda M, Shigeta Y. Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on progression of diabetic neuropathy and other microvascular complications: multivariate epidemiological analysis based on patient background factors and severity of diabetic neuropathy. Diabet Med 2012;29(12):1529-1533.
15. Kim YH, Kim YS, Kang SS, Cho GJ, Choi WS. Resveratrol inhibits neuronal apoptosis and elevated Ca2+/calmodulin-dependent protein kinase activity in diabetic mouse retina. Diabetes 2010; 59(7): 1825-1835.
16. Obrosova IG., Kador PF. Aldose reductase/polyol inhibitors for diabetic retinopathy. Curr Pharm Biotechnol 2011;12(3):373-385.
17. Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, Quagliaro L, Ceriello A, Giugliano D. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 2002;106(16):2067-2072.
18. Drel VR, Pacher P, Ali TK, Shin J, Julius U, El-Remessy AB, Obrosova IG. Aldose reductase inhibitor fidarestat counteracts diabetes-associated cataract formation, retinal oxidative-nitrosative stress, glial activation, and apoptosis. Int J Mol Med 2008;21(6):661-616.
19. Asnaghi V, Gerhardinger C, Hoehn T, Adeboje A, Lorenzi M. A role for the polyol pathway in the early neuroretinal apoptosis and glial changes induced by diabetes in the rat. Diabetes 2003;52(2):506-511.
20. Halterman JA, Kwon HM, Wamhoff BR, Tonicity-independent regulation of the osmosensitive transcription factor TonEBP (NFAT5). Am J Physiol Cell Physiol 2012;302(1):C1-8.
21. Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH. Mechanisms underlying inflammation in neurodegeneration. Cell 2010;140(6):918-934.